Sign Up to like & get
recommendations!
2
Published in 2022 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.1191
Abstract: SHR4640, also named as ruzinurad, is a selective human urate transporter 1 (URAT1) inhibitor developed for the treatment of hyperuricemia and gout. This study evaluated the high‐fat, high‐calorie food effect on the pharmacokinetics and pharmacodynamics…
read more here.
Keywords:
food;
dose shr4640;
healthy chinese;
male volunteers ... See more keywords